Search Results - "Martínez Ortega, PA"

4CPS-112 Assessment of aggressive care in oncology patients at the end of life in clinical practice by García Martín, E, Escudero Vilaplana, V, Collado Borrell, R, González-Haba Peña, E, Marzal Alfaro, B, Fox, B, Hoyo Muñoz, Á, Martínez Ortega, PA, Amor García, MÁ, Herranz Alonso, A, Sanjurjo Saéz, M

“…BackgroundThe correct management of oncology patients at the end of life, with less aggressive interventions and open access to hospice care, affects their…”
Get full text

PP-026 Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report by Martín, E García, López, MS Pernía, Monje, B, Ortega, PA Martínez, Navarro, C Ortega, Revuelta, JL, Martínez, C Ruiz, Alonso, A Herranz, Sáez, M Sanjurjo

“…BackgroundHereditary haemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu disease, is a rare, vascular, autosomal dominant disorder…”
Get full text

5PSQ-085 Metabolic disorders in patients treated with second-generation antipsychotics: an opportunity for pharmaceutical intervention by Melgarejo-Ortuño, A, Lobato-Matilla, ME, Revuelta-Herrero, JL, De Lorenzo-Pinto, A, García-González, X, García-Martín, E, Amor-García, MA, García-Sánchez, S, Martínez-Ortega, PA, Herranz-Alonso, A, Sanjurjo-Sáez, M

“…BackgroundSecond-generation antipsychotics (SGAs) have improved the treatment of psychiatric disorders. Nevertheless, their use is associated with the…”
Get full text

5PSQ-071 Evaluation of the effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease by Amor, MÁ, Lobato-Matilla, E, Giménez-Manzorro, Á, García-González, X, García-Martín, E, Melgarejo-Ortuño, A, Revuelta-Herrero, JL, Martínez-Ortega, PA, Ortega-Navarro, C, Herranz-Alonso, A, Sanjurjo-Sáez, M

“…BackgroundVedolizumab seems to be an alternative in the treatment of inflammatory bowel disease (IBD), but it needs real-world data to assess its…”
Get full text

5PSQ-078 Secukinumab for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in clinical practice by Martín, E García, Romero-Jiménez, R, Ais-Larisgoitia, A, Escudero-Vilaplana, V, Collado-Borrell, R, Martínez-Ortega, PA, Ortega-Navarro, C, Revuelta-Herrero, J, Amor-García, MA, García-Moreno, FJ, Sanjurjo-Sáez, M

“…BackgroundModerate to severe psoriasis is considered a multisystem disease that is associated with the risk of other comorbidities complex inflammatory…”
Get full text